SPC333
acalabrutínib eða lyfjafræðilega tækt salt þess
Status:
VeittApplication date:
26.4.2021Application published:
15.5.2021Grant published:
15.1.2023
Max expiry date:
5.11.2035Medicine name:
CalquenceMedicine for children:
No
Timeline
Today
26.4.2021Application
15.5.2021Publication
15.1.2023Registration
5.11.2035Expires
Marketing license
IS authorization number:
EU/1/20/1479/001-002Date:
10.11.2020
Foreign authorization number:
EU/1/20/1479Date:
5.11.2020
Owner
Name:
Merck Sharp & Dohme B.V.Address:
Waarderweg 39, BN Haarlem NL
Agent
Name:
Kjartan Ragnars, hrl.Address:
Hrauntungu 66, 200 Kópavogi
Patent
Number:
EP2734522